Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Tanja D de Gruijl"'
Autor:
Kristina Lundberg, Shahram Kordasti, Nathalie van Leeuwen-Kerkhoff, Tanja D. de Gruijl, Arjan A. van de Loosdrecht, Malin Lindstedt, Hetty J. Bontkes, Theresia M. Westers
Publikováno v:
Frontiers in Immunology
van Leeuwen-Kerkhoff, N, Lundberg, K, Westers, TM, Kordasti, S, Bontkes, HJ, Lindstedt, M, de Gruijl, TD & van de Loosdrecht, AA 2018, ' Human Bone Marrow-Derived Myeloid Dendritic Cells Show an Immature Transcriptional and Functional Profile Compared to Their Peripheral Blood Counterparts and Separate from Slan+ Non-Classical Monocytes ', Frontiers in Immunology, vol. 9, no. 1619 . https://doi.org/10.3389/fimmu.2018.01619
Frontiers in Immunology, Vol 9 (2018)
Frontiers in Immunology, 9(1619). Frontiers Media S.A.
van Leeuwen-Kerkhoff, N, Lundberg, K, Westers, TM, Kordasti, S, Bontkes, HJ, Lindstedt, M, de Gruijl, TD & van de Loosdrecht, AA 2018, ' Human Bone Marrow-Derived Myeloid Dendritic Cells Show an Immature Transcriptional and Functional Profile Compared to Their Peripheral Blood Counterparts and Separate from Slan+ Non-Classical Monocytes ', Frontiers in Immunology, vol. 9, no. 1619 . https://doi.org/10.3389/fimmu.2018.01619
Frontiers in Immunology, Vol 9 (2018)
Frontiers in Immunology, 9(1619). Frontiers Media S.A.
The human bone marrow (BM) gives rise to all distinct blood cell lineages, including CD1c+ (cDC2) and CD141+ (cDC1) myeloid dendritic cells (DC) and monocytes. These cell subsets are also present in peripheral blood (PB) and lymphoid tissues. However
Autor:
John P. Veluchamy, Nina Kok, Hans J. van der Vliet, Henk M. W. Verheul, Tanja D. de Gruijl, Jan Spanholtz
Publikováno v:
Frontiers in Immunology
Veluchamy, J P, Kok, N, van der Vliet, H J, Verheul, H M W, de Gruijl, T D & Spanholtz, J 2017, ' The rise of allogeneic Natural killer cells as a platform for cancer immunotherapy : Recent innovations and future developments ', Frontiers in Immunology, vol. 8, no. MAY, 631 . https://doi.org/10.3389/fimmu.2017.00631
Frontiers in Immunology, Vol 8 (2017)
Veluchamy, J P, Kok, N, van der Vliet, H J, Verheul, H M W, de Gruijl, T D & Spanholtz, J 2017, ' The rise of allogeneic Natural killer cells as a platform for cancer immunotherapy : Recent innovations and future developments ', Frontiers in Immunology, vol. 8, no. MAY, 631 . https://doi.org/10.3389/fimmu.2017.00631
Frontiers in Immunology, Vol 8 (2017)
Natural killer (NK) cells are critical immune effector cells in the fight against cancer. As NK cells in cancer patients are highly dysfunctional and reduced in number, adoptive transfer of large numbers of cytolytic NK cells and their potential to i
Autor:
Hans J. van der Vliet, Tanja D. de Gruijl, Fenna Bohme, Henk M.W. Verheul, Jan Spanholtz, James P. Di Santo, Daniëlle A.M. Heideman, Nina Kok, Silvia Lopez-Lastra, John P. Veluchamy
Publikováno v:
Veluchamy, J P, Lopez-Lastra, S, Spanholtz, J, Bohme, F, Kok, N, Heideman, D A M, Verheul, H M W, Di Santo, J P, de Gruijl, T D & van der Vliet, H J 2017, ' In Vivo efficacy of umbilical cord blood stem cell-derived NK cells in the treatment of metastatic colorectal cancer ', Frontiers in Immunology, vol. 8, no. FEB, 87 . https://doi.org/10.3389/fimmu.2017.00087
Frontiers in Immunology
Frontiers in Immunology, 8(FEB):87. Frontiers Media S.A.
Frontiers in Immunology
Frontiers in Immunology, 8(FEB):87. Frontiers Media S.A.
Therapeutic monoclonal antibodies against the epidermal growth factor receptor (EGFR) act by inhibiting EGFR downstream signaling and by eliciting a natural killer (NK) cell-mediated antitumor response. The IgG1 mAb cetuximab has been used for treatm